loperamide and colestipol

loperamide has been researched along with colestipol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Morgan, B	1
Barcenas, CH; Bose, R; Brufsky, A; Chan, A; Cheong, KA; Chien, AJ; DiPrimeo, D; Egle, D; Foruzan, N; García-Sáenz, JA; Hurvitz, SA; Marx, G; McCulloch, L; Pistilli, B; Rugo, HS; Ruiz-Borrego, M; Schnappauf, B; Semsek, D; Singer, CF; Thirlwell, M; Trudeau, M; Wassermann, J	1

Other Studies

2 other study(ies) available for loperamide and colestipol

Article	Year
Drug development: A healthy pipeline. Nature, 2016, 05-19, Volume: 533, Issue:7603 Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain	2016
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer. Breast (Edinburgh, Scotland), 2023, Volume: 67 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Budesonide; Colestipol; Diarrhea; Female; Humans; Incidence; Loperamide; Quality of Life; Receptor, ErbB-2	2023

Article

Year

Drug development: A healthy pipeline.

Nature, 2016, 05-19, Volume: 533, Issue:7603

Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain

2016

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.

Breast (Edinburgh, Scotland), 2023, Volume: 67

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Budesonide; Colestipol; Diarrhea; Female; Humans; Incidence; Loperamide; Quality of Life; Receptor, ErbB-2

2023